fa Descriptive & Survey <span style="font-size:10pt"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="background:white"><span cambria="" style="font-family:">Aims:</span></span></span></b><span style="font-size:9.0pt"><span style="background:white"><span cambria="" style="font-family:"> About one-third of breast cancer patients occur over 70 years old. Aging leads to the modification of a number of different drugs in the treatment of breast cancer, which provides the basis for incomplete treatment of these patients. The aim of this study was to evaluate the clinical features of breast cancer in elderly women.</span></span></span></span></span></span><br> <span style="font-size:10pt"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="background:white"><span cambria="" style="font-family:">Instrument & Methods:</span></span></span></b><span style="font-size:9.0pt"><span style="background:white"><span cambria="" style="font-family:"> This descriptive study was conducted in 2020 by reviewing the clinical records of all women with breast cancer over the age of 70 over a ten-year period ending in 2020 with a clinical record of 183 patients. Demographic information, type of tumor pathology, clinical stage of the tumor, status of hormone receptors and tumor HER2 protein, type of surgery, type of adjuvant treatment was extracted from the files and used.</span></span></span></span></span></span><br> <span style="font-size:10pt"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="background:white"><span cambria="" style="font-family:">Findings:</span></span></span></b><span style="font-size:9.0pt"><span style="background:white"><span cambria="" style="font-family:"> In 88 non-metastatic patients, there were 90 lymph nodes positive, of which 33 (37.5%) had no estrogen receptor and 55 (62.5%) had estrogen receptor. The most systemic treatment in patients with estrogen receptor-free tumor was chemotherapy (81.8%) and in patients with estrogen receptor tumor, chemotherapy plus hormone therapy (58.2%). there were 40 non-metastatic lymph node-negative patients, of which 9 (22.5%) had no estrogen receptor and 31 (77.5%) had estrogen receptor. The most systemic treatment received in patients without estrogen receptor was only chemotherapy (77.8%) and in patients with estrogen receptor tumor was only hormone therapy (54%).</span></span></span><span style="font-size:9.0pt"><span style="background:white"><span style="font-family:"Cambria",serif"></span></span></span></span></span></span><br> <span style="font-size:10pt"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="background:white"><span cambria="" style="font-family:">Conclusion:</span></span></span></b><span style="font-size:9.0pt"><span style="background:white"><span cambria="" style="font-family:"> The most common stage of the breast cancer in over 70 years old women is type IIB.</span></span></span></span></span></span><br> &nbsp; Breast Cancer, Surgery, Elderly 15 18 http://gmedicine.de/browse.php?a_code=A-10-1-20&slc_lang=fa&sid=2 F. Mahdavi 10031947532846001396 10031947532846001396 No Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran R. Eghdam Zamiri 10031947532846001397 10031947532846001397 Yes Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran